Related Experiment Video
Updated: Aug 9, 2026
08:54
Imaging Spatial Reorganization of a MAPK Signaling Pathway Using the Tobacco Transient Expression System
Published on: March 20, 2016
Interplay of the SUMO and MAP kinase pathways
1Faculty of Life Sciences, University of Manchester, UK.
Ernst Schering Research Foundation Workshop
|March 30, 2006
Summary
The SUMOylation pathway regulates transcriptional repressors, often via histone deacetylase (HDAC) recruitment. This study explores the interplay between SUMOylation and MAP kinase pathways, particularly in cancer.
Area of Science:
- Molecular Biology
- Epigenetics
- Cell Signaling
Background:
- The SUMO (Small Ubiquitin-like Modifier) modification pathway influences transcriptional regulation.
- Sumoylation typically results in repressive transcriptional properties, often through recruiting histone deacetylases (HDACs).
- The transcription factor Elk-1 serves as an example, where sumoylation recruits HDAC-2, and ERK MAP kinase activation reverses this.
Purpose of the Study:
- To discuss the evidence linking the SUMO and MAP kinase pathways.
- To explore potential regulatory events and their implications in cancer.
Main Methods:
- Literature review and synthesis of existing evidence.
- Discussion of regulatory mechanisms involving SUMOylation, HDACs, Elk-1, and MAP kinase pathways.
Main Results:
- Sumoylation generally represses transcription, often by recruiting HDACs.
- ERK MAP kinase pathway activation leads to desumoylation of Elk-1 and loss of HDACs.
- PIAS proteins exhibit both SUMO-dependent and -independent regulatory roles.
Conclusions:
- There is a complex interplay between the SUMO and MAP kinase pathways.
- Understanding these interactions is crucial for investigating their role in cancer development and progression.
More Related Videos
Related Concept Videos
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...